RSS   Newsletter   Contact   Advertise with us
Post Online Media

Concert Pharmaceuticals appoints two vice presidents

Concert PharmaceuticalsConcert Pharmaceuticals announced that Christine Boisclair has been appointed as VP of regulatory affairs and Scott Weintraub as VP, commercial and product strategy.

Ms. Boisclair joins Concert with more than 30 years of regulatory affairs experience in the biopharmaceutical industry across multiple therapeutic areas.

Prior to joining Concert, Ms. Boisclair was Vice President, Regulatory Affairs, at Forum Pharmaceuticals.

She held management roles at several companies including Insmed, Agennix, OSI Pharmaceuticals, Genzyme Corporation, Immulogic Pharmaceuticals and Parexel International.

Ms. Boisclair also worked in regulatory at Searle Pharmaceuticals and Glaxo in the U.K.

She received a Bachelor of Science Honors Degree in Biochemistry from the University of York in the U.K.

Mr. Weintraub joins Concert with more than 17 years of commercial experience in the biopharmaceutical industry, including strategic product assessment, brand positioning, commercial life cycle management, and sales and marketing.

Prior to joining Concert, Mr. Weintraub was Vice President of Product Strategy and Marketing at Forum Pharmaceuticals.

He also served as Senior Director of Marketing at Sunovion Pharmaceuticals and held sales and marketing positions at AstraZeneca.

Mr. Weintraub holds a B.S. in Finance and Marketing from Florida State University and an M.B.A. in Health Administration and Policy from University of Miami.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy